Clinical trial
Study of Photodynamic Therapy With WST09 in Patients With Recurrent or Persistent Localized Carcinoma of the Prostate Following Radiation Therapy
NCT00312442 is registered in ClinicalTrials.gov with STEBA France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Photodynamic Therapy With WST09 in Patients With Recurrent or Persistent Localized Carcinoma of the Prostate Following Radiation Therapy
- Lead sponsor
- STEBA France
- Phase
- Phase 2/3
- Overall status
- Terminated
- Start date
- May 31, 2006
- Completion date
- December 31, 2009
- Enrollment
- 16 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer